Thus, our study revealed that PmA induced T-cell immunodeficiency, and that the activation of Th17 cells/IL-17A via the IL-6–JAK2–STAT3 axis was a key mechanism against PmA. The gene discussed is IL6; the disease is T-cell immunodeficiency.